For 10 years, the global Bristol Myers Squibb workforce has come together to demonstrate its long-standing commitment to cancer research through the Country 2 Country 4 Cancer (Europe), Coast 2 Coast 4 Cancer (United States), and Continent 2 Continent 4 Cancer (Japan and Latin America) bike rides – collectively known as C2C4C. The tradition began in 2014 when a group of Oncology employees in the United States (U.S.) were compelled to do more for those impacted by cancer. Those efforts expanded to Europe in 2016, Japan in 2021 and Latin America in 2022.

The Company’s commitment is deeply rooted in its patient-centric culture and goes beyond day-to-day job responsibilities. In the U.S., across Europe, in Japan and in Latin America, the ride includes hundreds of employees representing more than 30 nations, who volunteer their time to train, fundraise and participate in these epic bike rides where their miles make more memories for cancer patients and their loved ones. For a decade, our employee riders’ motivation to participate and advance cancer research has been personal. Some are riding in honor of those who have lost their lives from cancer or are currently battling the disease. All are cycling for patients. Since its inception, more than $14 million has been donated to advance cancer research worldwide.

Follow MSCAN

• Facebook
• LinkedIn
• Instagram